Sex differences in neuropathic pain in longstanding diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes

Nancy Cardinez, Leif E. Lovblom, Johnny Wei Bai, Evan Lewis, Alon Abraham, Daniel Scarr, Julie A. Lovshin, Yuliya Lytvyn, Genevieve Boulet, Mohammed A. Farooqi, Andrej Orszag, Alanna Weisman, Hillary A. Keenan, Michael H. Brent, Narinder Paul, Vera Bril, David Z. Cherney, Bruce A. Perkins*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Aim: Neuropathy and neuropathic pain are common complications of type 1 diabetes (T1D). We aimed to determine if sex-specific differences in neuropathic pain are present in adults with longstanding T1D. Methods: Canadians with ≥50 years of T1D (n = 361) completed health history questionnaires that included assessment of neuropathy (defined by Michigan Neuropathy Screening Instrument questionnaire components ≥3; NEUROPATHYMNSI-Q) and neuropathic pain. Multivariable logistic regression was used to determine sex-differences in neuropathic pain controlling for neuropathy. Results: Participants had mean age 66 ± 9 years, median diabetes duration 53[51,58] years, mean HbA1c 7.5 ± 1.0%, and 207(57%) were female. Neuropathic pain was present in 128(36%) of all participants, more prevalent among those with NEUROPATHYMNSI-Q compared to those without [96(63%) vs. 31(15%), p < 0.001], and more prevalent in females compared to males [87(42%) vs. 41(27%), p = 0.003]. Independent of the presence of NEUROPATHYMNSI-Q and other factors, female sex was associated with the presence of neuropathic pain [OR 2.68 (95% CI 1.4–5.0), p = 0.002]. Conclusions: We demonstrated a novel sex-specific difference in neuropathic pain in females compared to males with longstanding T1D, independent of the presence of neuropathy. Further research using more objective measures of neuropathy than the MNSI is justified to further understand this sex-specific difference.

Original languageEnglish
Pages (from-to)660-664
Number of pages5
JournalJournal of Diabetes and its Complications
Volume32
Issue number7
DOIs
StatePublished - Jul 2018

Funding

FundersFunder number
Canadian Clinical Trial Network
Glaxo Smith Kline Canada
AstraZeneca
Johnson and Johnson
Merck
Roche
Sanofi
Medtronic
Boehringer Ingelheim
Juvenile Diabetes Research Foundation Canada17-2013-312
Novo Nordisk

    Keywords

    • Gender
    • Neuropathic pain
    • Neuropathy
    • Pain
    • Sex
    • Type 1 diabetes

    Fingerprint

    Dive into the research topics of 'Sex differences in neuropathic pain in longstanding diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes'. Together they form a unique fingerprint.

    Cite this